Comparing a Monthly Replacement Lens Versus a Daily Disposable Lens

November 20, 2024 updated by: CooperVision, Inc.

Comparing Clariti Elite Versus Proclear 1 Day

The purpose of this study was to compare subjective ratings of lens handling at insertion for a monthly replacement lens versus a daily disposable lens in habitual soft lens wearers.

Study Overview

Status

Completed

Conditions

Detailed Description

This was a non-dispensing, randomized, double-masked, crossover study. Participants wore 2 different contact lenses bilaterally over 4 study visits, all conducted on the same day. Estimated duration of involvement for each participant was 4 hours.

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ontario
      • Waterloo, Ontario, Canada, N2L 3G1
        • University of Waterloo School of Optometry & Vision Science

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. Were 17 to 40 years of age and have full legal capacity to volunteer;
  2. Had read and signed an information consent letter;
  3. Were willing and able to follow instructions and maintain the appointment schedule;
  4. Were habitual daily wearers of spherical single vision soft contact lenses to correct for distance vision in each eye
  5. Were correctable to a visual acuity of 20/20 or better (in each eye) with sphero-cylindrical subjective refraction;
  6. Had an astigmatism of ≤ 0.75DC in subjective refraction;
  7. Could be fit with the study contact lenses with a power between -1.00 and -6.00DS; this translates to best corrected vision sphere refraction that vertexes to a CL power between -1.00 and -6.00 (inclusive) at screening visit.
  8. Demonstrated an acceptable fit with the study lenses.

Exclusion Criteria:

  1. Had taken part in another clinical research study within the last 14 days;
  2. Were currently habitual wearers of toric, multifocal or monovision lenses.
  3. Had worn any rigid contact lenses in the past 6 months
  4. Were an extended lens wearer (i.e., sleeping with their lenses)
  5. Had a difference of ≥1.5 D in best vision sphere subjective refraction between eyes;
  6. Had amblyopia and/or distance strabismus/binocular vision problem;
  7. Had any known active ocular disease, allergies and/or infection;
  8. Had a systemic condition that in the opinion of the investigator may affect a study outcome variable;
  9. Were using any systemic or topical medications that in the opinion of the investigator may affect a study outcome variable;
  10. Had a known sensitivity to the diagnostic pharmaceuticals to be used in the study;
  11. Had undergone refractive error surgery or intraocular surgery;
  12. Were a member of CORE directly involved in the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Control Lens, then Test Lens
Participants wore the Control Lens for 90 minutes, then the Test Lens for 90 minutes.
Daily disposable contact lens for 90 minutes
Monthly replacement contact lens for 90 minutes
Experimental: Test Lens, then Control Lens
Participants wore the Test Lens for 90 minutes, then the Control Lens for 90 minutes.
Daily disposable contact lens for 90 minutes
Monthly replacement contact lens for 90 minutes

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Lens Handling at Insertion
Time Frame: Immediately after lens application
Participants completed subjective ratings of the ease of application of the study lenses to eye immediately after lens application on a 0-100 integer scale, where 100=very easy and 0=very difficult.
Immediately after lens application

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Lyndon Jones, PhD FCOptom, Centre for Ocular Research and Education (CORE)

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 28, 2023

Primary Completion (Actual)

November 22, 2023

Study Completion (Actual)

November 22, 2023

Study Registration Dates

First Submitted

September 14, 2023

First Submitted That Met QC Criteria

September 19, 2023

First Posted (Actual)

September 21, 2023

Study Record Updates

Last Update Posted (Estimated)

December 12, 2024

Last Update Submitted That Met QC Criteria

November 20, 2024

Last Verified

January 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • CV-23-36

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Myopia

Clinical Trials on Control Lens

Subscribe